Two Cross-Protective Antigen Sites on Foot-and-Mouth Disease Virus Serotype O Structurally Revealed by Broadly Neutralizing Antibodies from Cattle

2021 ◽  
Vol 95 (21) ◽  
Author(s):  
Kun Li ◽  
Yong He ◽  
Li Wang ◽  
Pinghua Li ◽  
Sheng Wang ◽  
...  

FMDV is the causative agent of foot-and-mouth disease (FMD), which is one of the most contagious and economically devastating diseases of domestic animals. The antigenic structure of FMDV serotype O is rather complicated, especially for those sites that can elicit a cross-protective neutralizing antibody response.

2019 ◽  
Vol 57 (12) ◽  
Author(s):  
Yimei Cao ◽  
Kun Li ◽  
Sheng Wang ◽  
Yuanfang Fu ◽  
Pu Sun ◽  
...  

ABSTRACT Vaccination with inactivated vaccines is still the main measure to control foot-and-mouth disease (FMD) in areas where the disease is endemic, and the level of neutralizing antibody in vaccinated animals is directly related to their protection against virus challenge. Currently, neutralizing antibody is mainly detected using the virus neutralization test (VNT) based on cell culture, which is laborious and time-consuming and requires restrictive biocontainment facilities. In this study, two broadly neutralizing antibodies (bnAbs), E46 and F128, were successfully produced using techniques for the isolation of single B cells from peripheral blood mononuclear cells (PBMCs) from bovines sequentially immunized with three topotypes of foot-and-mouth disease virus (FMDV) serotype O. Based on these bnAbs, a blocking enzyme-linked immunosorbent assay (ELISA) for detecting neutralizing antibodies (NA-ELISA) against FMDV serotype O was developed. The specificity and sensitivity of the test were estimated to be 99.21% and 100%, respectively. A significant correlation (P < 0.01) was observed between the NA-ELISA titers and the VNT titers for all sera from vaccinated animals and for all tested strains, suggesting that the NA-ELISA could detect neutralizing antibodies against FMDV serotype O strains of wide antigenic and molecular diversity and could be used for the evaluation of protective immunity.


2021 ◽  
pp. 104914
Author(s):  
Zahra Naeem ◽  
Sohail Raza ◽  
Saba Afzal ◽  
Ali Ahmad Sheikh ◽  
Muhammad Muddassir Ali ◽  
...  

2005 ◽  
Vol 11 (12) ◽  
pp. 1887-1893 ◽  
Author(s):  
Nick J. Knowles ◽  
Alan R. Samuel ◽  
Paul R. Davies ◽  
Rebecca J. Midgley ◽  
Jean-François Valarcher

Vaccine ◽  
2014 ◽  
Vol 32 (21) ◽  
pp. 2446-2451 ◽  
Author(s):  
Eduardo Maradei ◽  
Viviana Malirat ◽  
Claudia Perez Beascoechea ◽  
Ana María Espinoza ◽  
Sabrina Galdo Novo ◽  
...  

2015 ◽  
Vol 215-216 ◽  
pp. 45-51 ◽  
Author(s):  
Jitendra K. Biswal ◽  
Punam Bisht ◽  
Jajati K. Mohapatra ◽  
Rajeev Ranjan ◽  
Aniket Sanyal ◽  
...  

2006 ◽  
Vol 158 (6) ◽  
pp. 201-203 ◽  
Author(s):  
U. Wernery ◽  
P. Nagy ◽  
C. M. Amaral-Doel ◽  
Z. Zhang ◽  
S. Alexandersen

Sign in / Sign up

Export Citation Format

Share Document